Jounce Therapeutics Overview

Jounce Therapeutics Operating Income

Operating Income for JNCE.

Quarterly Operating Income

$50.34M

↑ 167719.04% YoY

As of Dec 31, 2022

Annual Operating Income (TTM)

$-52242000.00

↓ 14% YoY

Trailing 12 months ending Dec 31, 2022

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin